Aptabio Therapeutics, Inc.
Aptabio Therapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | Advanced Solid Cancer; Advanced Solid Tumor (Phase 1) | Recruiting | Phase 1 | 2026-10-09 | NCT07123415 | |
| A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 | 2026-02-06 | NCT07330674 | |
| Efficacy and Safety Study of Isuzinaxib in Subjects With DKD | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, diabetes mellitus, diabetic kidney disease, endocrine system disorder, kidney disorder, urinary system disorder | Recruiting | Phase 2 | 2025-07-18 | NCT06962098 |